Skip to main content

Advertisement

SpringerLink
Log in

Quantitative profiling of codon 816 KIT mutations can aid in the classification of systemic mast cell disease

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Akin C, Jaffe ES, Raffeld M, Kirshenbaum AS, Daley T, Noel P et al. An immunohistochemical study of the bone marrow lesions of systemic mastocytosis: expression of stem cell factor by lesional mast cells. Am J Clin Pathol 2002; 118: 242–247.

    Article  CAS  PubMed  Google Scholar 

  2. Longley BJ, Tyrrell L, Lu SZ, Ma YS, Langley K, Ding TG et al. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 1996; 12: 312–314.

    Article  CAS  PubMed  Google Scholar 

  3. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995; 92: 10560–10564.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Taylor ML, Sehgal D, Raffeld M, Obiakor H, Akin C, Mage RG et al. Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis. J Mol Diagn 2004; 6: 335–342.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Garcia-Montero AC, Jara-Acevedo M, Teodosio C, Sanchez ML, Nunez R, Prados A et al. KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 2006; 108: 2366–2372.

    Article  CAS  PubMed  Google Scholar 

  6. Valent P, Metcalfe DD, Horny H-P, Parwaresch RM, Li CY, Bennett JM et al. Mastocytosis. In: Jaffe ES, Harris N, Stein H & Vardiman JW (eds) Tumours of Hematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2001, 292–302.

    Google Scholar 

  7. Nordstrom T, Ronaghi M, Forsberg L, de Faire U, Morgenstern R, Nyren P . Direct analysis of single-nucleotide polymorphism on double-stranded DNA by pyrosequencing. Biotechnol Appl Biochem 2000; 31 (Pt 2): 107–112.

    Article  CAS  PubMed  Google Scholar 

  8. Schittenhelm MM, Shiraga S, Schroeder A, Corbin AS, Griffith D, Lee FY et al. Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies. Cancer Res 2006; 66: 473–481.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pathology and Laboratory Medicine, Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    W Zhao, C E Bueso-Ramos, B A Barkoh, A A Khitamy & D Jones

  2. Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    S Verstovsek

Authors
  1. W Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C E Bueso-Ramos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Verstovsek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B A Barkoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A A Khitamy
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D Jones.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, W., Bueso-Ramos, C., Verstovsek, S. et al. Quantitative profiling of codon 816 KIT mutations can aid in the classification of systemic mast cell disease. Leukemia 21, 1574–1576 (2007). https://doi.org/10.1038/sj.leu.2404680

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404680

  • Springer Nature Limited

This article is cited by

Search

Navigation